Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Cáncer
6
Agentes antineoplásicos
2
Aspectos moleculares
2
Diagnóstico
2
Histopatología
2
Carcinogénesis química
1
Citodiagnóstico
1
Enfermedades
1
Enfermedades de la próstata
1
Enfermería
1
Farmacología
1
Inmunodiagnóstico
1
Mamas
1
Merkel celulas
1
Merkel celulas carcinoma
1
Oncología
1
Patofisiología
1
Próstata
1
Quimioterapia
1
-
2721
-
2722por Hatano, Masako, Takenaka, Yasuhiro, Inoue, Ikuo, Homma, Keiko, Hasegawa, Tomonobu, Sasano, Hisanobu, Awata, Takuya, Katayama, Shigehiro“…Because feminizing adrenocortical carcinoma was suspected, right adrenalectomy was performed; the pathological diagnosis was adrenocortical carcinoma. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2723por Takeda, Kazuya, Matsushita, Haruo, Kubozono, Masaki, Tanabe, Takaya, Ishikawa, Yojiro, Yamamoto, Takaya, Kozumi, Maiko, Takahashi, Noriyoshi, Katagiri, Yu, Tasaka, Shun, Fukui, Katsuya, Takeda, Ken, Fujishima, Fumiyoshi, Ichinose, Masakazu, Jingu, Keiichi“…Pulmonary sarcomatoid carcinoma is a rare subtype of non-small cell lung cancer with a poor prognosis. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2724
-
2725por Girardi, Fábio Muradás“…Objective The objective of this study is to analyze the clinicopathological pattern of thyroid carcinoma presentation according to age groups. Methods This is a retrospective study. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2726
-
2727por Strong, Theresa V“…Advances in gene transfer technology have greatly expanded the opportunities for developing immunotherapy strategies for breast carcinoma. Genetic immunotherapy approaches include the transfer of genes encoding cytokines and costimulatory molecules to modulate immune function, as well as genetic immunization strategies which rely on the delivery of cloned tumor antigens. …”
Publicado 2000
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
2728
-
2729por Kerkeni, W., Ayari, Y., Charfi, L., Bouzouita, A., Ayed, H., Cherif, M., Ben Slama, M.R., Mrad, K., Derouiche, A., Chebil, M.“…Skin biopsy confirmed cutaneous metastasis from urothelial carcinoma.…”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2730“…We elucidate major pathways of hepatocarcinogenesis and accurate diagnostic metabolomic biomarkers of hepatocellular carcinoma (HCC) identified by contemporary HCC metabolomics studies, and delineate a model HCC metabolomics study design. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2731por Guo, Hongbo, Zhong, Weifeng, Wang, Xiaohong, Pan, Bin, Li, Feng, Lu, Kuang, Su, Zexuan, Zhang, Shiqing“…The aim of the present study was to assess the association between renal carcinoma (RC) and Apollon expression, and to highlight the link between Apollon expression and the occurrence, development and prognosis of RC. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2732
-
2733
-
2734por van der Putten, Louis J. M., van de Vijver, Koen, Bartosch, Carla, Davidson, Ben, Gatius, Sonia, Matias-Guiu, Xavier, McCluggage, W. Glenn, Toledo, Gemma, van der Wurff, Anneke A. M., Pijnenborg, Johanna M. A., Massuger, Leon F. A. G., Bulten, Johan“…Myometrial invasion (MI) as a percentage (%MI), categorized into <50 or ≥50 %, is an important predictor of prognosis in endometrial carcinoma. Recent studies suggest that tumor-free distance (TFD) to serosa and the absolute depth of invasion (DOI) might be stronger predictors of prognosis. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2735
-
2736“…All cells, including carcinoma cells, increase uptake of blood nutrients, meaning the vascular profile is influential to tumor growth and progression. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2737
-
2738por Bedke, Jens, Gauler, Thomas, Grünwald, Viktor, Hegele, Axel, Herrmann, Edwin, Hinz, Stefan, Janssen, Jan, Schmitz, Stephan, Schostak, Martin, Tesch, Hans, Zastrow, Stefan, Miller, Kurt“…PURPOSE: Current systemic treatment of targeted therapies, namely the vascular endothelial growth factor-antibody (VEGF-AB), VEGF receptor tyrosine kinase inhibitor (TKI) and mammalian target of rapamycin (mTOR) inhibitors, have improved progression-free survival and replaced non-specific immunotherapy with cytokines in metastatic renal cell carcinoma (mRCC). METHODS: A panel of experts convened to review currently available phase 3 data for mRCC treatment of approved agents, in addition to available EAU guideline data for a collaborative review as the plurality of substances offers different options of first-, second- and third-line treatment with potential sequencing. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2739
-
2740